For the quarter ended December 2023, Collegium Pharmaceutical (COLL) reported revenue of $149.75 million, up 15.5% over the same period last year. EPS came in at $1.58, compared to $1.09 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $147.66 million, representing a surprise of +1.41%. The company delivered an EPS surprise of +18.80%, with the consensus EPS estimate being $1.33.While investors closely watch year-over-year changes in headline numbers -- revenue and ea ...